Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Expression of Smac induced by the Egr1 promoter enhances the radiosensitivity of breast cancer cells

Abstract

Breast cancer is one of the most prevalent cancers worldwide. Moreover, despite advances in antineoplastic therapies, induction of tumor cell death without off-target cytotoxicity remains a challenge. However, recent developments in localized radiotherapy and gene therapy have provided an opportunity to explore the potential for these strategies to be additive for the induction of cell death in tumor cells. Here, a novel adenoviral shuttle vector containing the proapoptotic gene Smac under the control of the ionizing radiation (IR)-induced Egr1 promoter was constructed. Following the transient transfection of the construct into MCF-7 and MDA-MB-435 breast cancer cell lines, acute and abundant expression of Smac was observed in response to IR treatment. Further analysis confirmed that the induction of Smac expression resulted in a decrease in cell viability, a slower rate of cell growth, a higher level of apoptosis and altered cell cycle progression. Using a clonogenic assay, IR-induced Smac expression was also found to significantly sensitize Smac-expressing cells to radiation-induced cell death. Taken together, these data suggest that Smac expression driven by the Egr1 promoter has the potential to serve as a radiotherapy-dependent gene therapy agent.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

Accession codes

Accessions

Gene Expression Omnibus

References

  1. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011; 378: 1461–1484.

    Article  Google Scholar 

  2. Dachs GU, Dougherty GJ, Stratford IJ, Chaplin DJ . Targeting gene therapy to cancer: a review. Oncol Res 1997; 9: 313–325.

    CAS  PubMed  Google Scholar 

  3. Weichselbaum RR, Hallahan DE, Sukhatme VP, Kufe DW . Gene therapy targeted by ionizing radiation. Int J Radiat Oncol Biol Phys 1992; 24: 565–567.

    Article  CAS  Google Scholar 

  4. Hu Y, Ouyang W, Wu F, Cao CH, Wang K, Liao ZK et al. Enhanced radiosensitivity of SW480 cells via TRAIL up-regulation mediated by Egr-1 promoter. Oncol Rep 2009; 22: 765–771.

    CAS  PubMed  Google Scholar 

  5. Li Y, Guo C, Wang Z, Gong P, Sun Z, Gong S et al. Enhanced effects of TRAIL-endostatin-based double-gene-radiotherapy on suppressing growth, promoting apoptosis and inducing cell cycle arrest in vascular endothelial cells. J Huazhong Univ Sci Technolog Med Sci 2012; 32: 167–172.

    Article  CAS  Google Scholar 

  6. Li YB, Guo CX, Wang ZC, Dong LH, Guan F, Liu Y et al. Radiosensitization of breast cancer cells by TRAIL-endostatin-targeting gene therapy. Neoplasma 2013; 60: 613–619.

    Article  CAS  Google Scholar 

  7. Vaux DL, Silke J . Mammalian mitochondrial IAP binding proteins. Biochem Biophys Res Commun 2003; 304: 499–504.

    Article  CAS  Google Scholar 

  8. Toulany M, Dittmann K, Krüger M, Baumann M, Rodemann HP . Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway. Radiother Oncol 2005; 76: 143–150.

    Article  CAS  Google Scholar 

  9. Toulany M, Schickfluss TA, Eicheler W, Kehlbach R, Schittek B, Rodemann HP et al. Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation. Breast Cancer Res 2011; 13: R28.

    Article  CAS  Google Scholar 

  10. Yang TJ, Ho AY . Radiation therapy in the management of breast cancer. Surg Clin North Am 2013; 93: 455–471.

    Article  Google Scholar 

  11. Qin S, Yang C, Li S, Xu C, Zhao Y, Ren H et al. Smac: its role in apoptosis induction and use in lung cancer diagnosis and treatment. Cancer Lett 2012; 318: 9–13.

    Article  CAS  Google Scholar 

  12. Martinez-Ruiz G, Maldonado V, Ceballos-Cancino G, Grajeda JP, Melendez-Zajgla J . Role of Smac/DIABLO in cancer progression. J Exp Clin Cancer Res 2008; 27: 48.

    Article  Google Scholar 

  13. Marignol L, Coffey M, Hollywood D, Lawler M . Radiation to control transgene expression in tumors. Cancer Biol Ther 2007; 6: 1005–1012.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Medjaden Bioscience Limited for assisting in the preparation of this manuscript. This project was supported by the National Natural Science Foundation of China (Grant No. 30970681).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C-H Lin.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Cancer Gene Therapy website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, ZL., Liang, S., Wang, ZC. et al. Expression of Smac induced by the Egr1 promoter enhances the radiosensitivity of breast cancer cells. Cancer Gene Ther 21, 142–149 (2014). https://doi.org/10.1038/cgt.2014.9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2014.9

This article is cited by

Search

Quick links